HIROTSU BIO SCIENCE INC.
PrivateLast Round
Corporate Funding
Mar 31, 2025
Est. Valuation
$948.77M
Total Funding Raised
$18.03M
Company Overview
HIROTSU BIO SCIENCE INC. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Corporate Funding round in March 2025.
HIROTSU BIO SCIENCE INC. is a biotechnology company that developed N-NOSE, a cancer screening test that utilizes the olfactory sensory functions of nematodes to detect cancer from urine samples.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2C
Customer Profile
Usage-Based SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HIROTSU BIO SCIENCE INC. Comparables
Compare HIROTSU BIO SCIENCE INC. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SalivaTech Co., Ltd. | 78% | |
| Craif Inc. | 76% | |
| Blue Industries | 75% |
For institutional investors. Book with your work email.
HIROTSU BIO SCIENCE INC. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 31, 2025 | ||||
| Corporate Funding | Aug 2, 2024 | ||||
| Corporate Funding | Dec 1, 2023 | ||||
| Corporate Funding | Aug 23, 2022 | ||||
| Corporate Funding | Mar 11, 2022 | ||||
Corporate Funding | Feb 16, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 31, 2025
Completed a corporate funding round.
- Aug 2, 2024
Received funding from Eastern Car Liner, Ltd.
For institutional investors. Book with your work email.
HIROTSU BIO SCIENCE INC. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HIROTSU BIO SCIENCE INC.'s valuation, stock price, and market status.
Is HIROTSU BIO SCIENCE INC. a public or private company?
HIROTSU BIO SCIENCE INC. is a private company.
What is the current stock price of HIROTSU BIO SCIENCE INC.?
HIROTSU BIO SCIENCE INC. is a private company, so its shares have no public market price. Caplight tracks HIROTSU BIO SCIENCE INC.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HIROTSU BIO SCIENCE INC. worth (valuation)?
HIROTSU BIO SCIENCE INC.'s valuation is estimated at $948.8M based on funding round data.
Can I buy HIROTSU BIO SCIENCE INC. stock?
HIROTSU BIO SCIENCE INC. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HIROTSU BIO SCIENCE INC.'s last funding round?
HIROTSU BIO SCIENCE INC.'s most recent funding round was Corporate Funding on March 31, 2025.
Who are the main investors in HIROTSU BIO SCIENCE INC.?
Investor information for HIROTSU BIO SCIENCE INC. is not publicly disclosed.
Will HIROTSU BIO SCIENCE INC. IPO soon?
No public IPO plans have been announced for HIROTSU BIO SCIENCE INC..
How can I track HIROTSU BIO SCIENCE INC. secondary market activity?
Caplight tracks bids, offers, and trades in HIROTSU BIO SCIENCE INC.'s shares on secondary markets.